EU: EC to combat top generic makers’ pay-for-delay deals next month (Competition Policy International)

The European Commission could issue fines to the world’s largest generic drug makers as early as next month, according to unnamed sources.

Leading generic firms Teva Pharmaceutical and Les Laboratoires Servier, along with other generic competitors, are under the Commission’s crackdown for alleged anticompetitive agreements made with brand name rivals, deals …read more

Source: Global Competition Law Blogs